| Authors: |
Gruijs M; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands., Braster R; Genmab, Uppsalalaan 15, Utrecht, Netherlands., Overdijk MB; Genmab, Uppsalalaan 15, Utrecht, Netherlands., Hellingman T; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands., Verploegen S; Genmab, Uppsalalaan 15, Utrecht, Netherlands., Korthouwer R; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands., van der Wilk BJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands., Parren PWHI; Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Albinusdreef 2, Leiden, Netherlands.; Lava Therapeutics, Yalelaan 60, Utrecht, Netherlands., van der Vliet HJ; Lava Therapeutics, Yalelaan 60, Utrecht, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands., Bögels M; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands., van Egmond M; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands. |